Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis
Crossref DOI link: https://doi.org/10.1136/bmjopen-2018-023458
Published Online: 2019-07-23
Published Print: 2019-07
Update policy: https://doi.org/10.1136/crossmarkpolicy
Kanters, Steve
Wilkinson, Lars
Vrazic, Hrvoje
Sharma, Rohini
Lopes, Sandra
Popoff, Evan
Druyts, Eric
Funding for this research was provided by:
Novo Nordisk A/S